Intracellular Bacterial Imprinting Enables Preservable Whole‐Cell Vaccination
Whole‐tumor‐cell vaccines preserve broad tumor‐antigen repertoires, but converting living tumor cells into safe and intrinsically immunogenic vaccine substrates remains challenging. Here we generated bacteria‐imprinted tumor (BiT) cells through the controlled internalization of attenuated Salmonella and subsequently prepared them as nonproliferative cellular vaccines by freeze‐drying. Within a defined bacterial‐loading window, intracellular Salmonella induced endoplasmic reticulum stress‐associated immunogenic preprogramming while preserving tumor‐cell integrity, thereby enhancing danger‐signal exposure, antigen‐presentation capacity, and immune visibility. Freeze‐drying preserved the bacteria‐induced immunogenic imprint by retaining key molecular and functional attributes while maintaining overall cellular architecture and markedly reducing residual bacterial viability. Vaccination with freeze‐dried BiT (FD‐BiT) cells elicited coordinated innate and adaptive immune responses, including antigen‐presenting cell activation, T follicular helper‐B‐cell cooperation, and germinal‐center formation. This coordinated T–B cell response was accompanied by durable memory formation and enhanced intratumoral CD8 + T‐cell infiltration, proliferation, and functional maintenance. Accordingly, FD‐BiT reduced primary tumor establishment and pulmonary metastasis and restrained the growth of tumors that emerged despite prophylactic vaccination. These findings establish intracellular bacterial programming and freeze‐drying‐mediated imprint preservation as a cell‐engineering principle for whole‐tumor‐cell vaccination.
Authors
- Daining Zhang
- Weidong Nie (ORCID: https://orcid.org/0000-0002-6723-0287)
- Furen Zhang (ORCID: https://orcid.org/0000-0002-3383-1973)
- Guihong Lu (ORCID: https://orcid.org/0000-0002-9160-9588)
- Hai-Yan Xie (ORCID: https://orcid.org/0009-0008-8208-7168)
- Zhongqin Tian
- Weixiu Wang
- Jichuan Chen
- Xing Liu (ORCID: https://orcid.org/0000-0002-3794-3569)
- Zhenyu Lu
Institutions
- Beijing Institute of Technology (CN)
- Peking University (CN)
- Shantou University Medical College (CN)
- Shenzhen Children's Hospital (CN)
- State Key Laboratory of Natural and Biomimetic Drugs (CN)
Publication Details
- Journal
- Advanced Materials
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1002/adma.75745
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Natural Science Foundation of Beijing Municipality
- Natural Science Foundation of Shandong Province
- National Key Research and Development Program of China
- National Science Fund for Distinguished Young Scholars
- Shenzhen Science and Technology Innovation Program